Trial Profile
Second Study of the Effect of Teriparatide on Femoral Neck Fracture Healing.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2022
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Hip fracture
- Focus Registrational; Therapeutic Use
- Acronyms GHDQ
- Sponsors Eli Lilly and Company
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Feb 2013 Planned end date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.